🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...
Status
Completed
Location
AOU Careggi- University of Florence
Start Date
2021-03-24
Trial ID
NCT04806906
Treatments Being Tested
Myelodysplastic Syndrome (MDS) is a group of blood disorders where the bone...
Status
Completed
Location
Calvary Mater Newcastle
Start Date
2018-05-18
Trial ID
NCT03493646
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of CC-486 ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2015-02-13
Trial ID
NCT02269943
Treatments Being Tested
The purpose of this study is to determine whether a tablet form of azacitid...
Status
Completed
Location
University of Florida
Start Date
2007-09-11
Trial ID
NCT00528983
Treatments Being Tested
Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Status
Completed
Location
Local Institution - 113
Start Date
2015-07-06
Trial ID
NCT02281084
Treatments Being Tested
The goal of the study is to identify a dose and schedule of CC-486 that can...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2015-04-29
Trial ID
NCT02343536
Treatments Being Tested
The purpose of the study is to determine the maximal tolerated dose and sch...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center.
Start Date
2013-10-25
Trial ID
NCT01835587
Treatments Being Tested
The purpose of this study is to evaluate the effect of moderate or severe l...
Status
Terminated
Location
Local Institution - 0083
Start Date
2024-07-12
Trial ID
NCT05209295
Treatments Being Tested
This study will evaluate a new maintenance therapy with the aim of improvin...
Status
Completed
Location
The Queen Elizabeth Hospital
Start Date
2019-06-14
Trial ID
NCT04173533
Treatments Being Tested
This study focuses on finding a safe and tolerable dose for a three-drug re...
Status
Terminated
Location
University of Chicago Medical Center
Start Date
2021-09-01
Trial ID
NCT04722601
Treatments Being Tested